Dr. Sozzi Gabriella

Gabriella Sozzi graduated in Biological Sciences, PhD in Medical Genetics and trained in USA at MSKCC  (NY, USA) and  Kimmel Cancer Center (PHL, USA). 

She was President of the Italian Cancer Society (SIC) from 2014 to 2022 and member of the scientific advisory boards of American-Italian Foundation for Cancer Research (AICF) and Associazione Italiana Ricerca Cancro (AIRC). She has coordinated the research area on ‘primary, secondary prevention & early detection’ of the Italian Ministry of Health at INT Milan from 2018 until 2023. She seats in the scientific advisory board of DIORAMA excellence project at the University of Torino, Italy. 

She received a the Award for Excellence in Medicine from AICF in 2002 and the Joseph W. Cullen Prevention/ Early Detection Award  in 2021.  

She is Associate Editor of the Journal of Thoracic Oncology from 2012 and member of the IASLC Early Detection and Screening Committee. 

Her research activity is centered on all aspects of lung cancer by using an integrated approach that combines cellular and molecular biology, biochemistry and pharmacology to gain new insights in the pathogenesis of lung cancer and on novel ways to provide early diagnosis and treatment options. The goal of her translational studies is the implementation of highly sensitive molecular tests that could be used within screening programs to improve both detection and clinical management of lung cancer. 

She has (co)authored 282 peer-reviewed publications; 18,648 citations, H-index 72 (Scopus 2025).